Fmoc-Cys(t-butylcarboxymethyl)-OH

Fmoc-Cys(t-butylcarboxymethyl)-OH is an Fmoc-protected cysteine derivative bearing a thiol side chain masked as a t-butylcarboxymethyl (tBu-Cm) thioether-protecting group, providing a stable chiral amino acid building block for peptide assembly. The molecule contains an Fmoc carbamate on the α-amino group and a free carboxylic acid, enabling controlled N-terminal deprotection and subsequent coupling while maintaining side-chain protection during chain elongation. The stereogenic center at the cysteine α-carbon is preserved, and the sulfur functionality is rendered non-nucleophilic under standard peptide synthesis conditions, reducing disulfide scrambling and side reactions. The tBu-Cm group is designed for selective removal to reveal the reactive cysteine thiol for downstream conjugation, native cysteine mimicry, or further functional group transformations.

1. Peptide Synthesis

Fmoc-Cys(t-butylcarboxymethyl)-OH supports solid-phase peptide synthesis workflows where Fmoc removal exposes the α-amine for iterative peptide coupling. The protected thiol side chain, carried by the t-butylcarboxymethyl group, remains inert toward common coupling reagents and bases, helping maintain sequence integrity during N-terminal elongation. The free C-terminal carboxylic acid functionality participates in amide bond formation, while the preserved cysteine stereochemistry helps generate peptide analogs with defined side-chain geometry. Post-synthesis thiol deprotection can enable formation of native-like cysteine motifs, disulfide-directed architectures, or thiol-reactive handles for subsequent derivatization.

2. Side-Chain Functionalization

Fmoc-Cys(t-butylcarboxymethyl)-OH serves as a controlled precursor for thiol-revealing amino acid modification strategies used in chemical biology and synthetic organic chemistry. The tBu-Cm protecting group suppresses premature thiol reactivity, allowing the molecule to be handled and incorporated into larger scaffolds before conversion to a free cysteine thiol. Thiol unmasking can then enable targeted reactions such as alkylation, acylation, or conjugation to electrophiles for generating thioether or thioester linkages. Downstream functionalization of the cysteine side chain supports construction of reactive intermediates for labeling, immobilization, and preparation of sulfur-containing building blocks.

3. Bioconjugation Chemistry

Fmoc-Cys(t-butylcarboxymethyl)-OH is applicable to bioconjugation workflows that require cysteine-equivalent reactive sites introduced with stereochemical control. The Fmoc-protected amine and protected thiol enable stepwise synthesis of peptide or linker frameworks that can be deprotected under conditions compatible with biomolecule-reactive steps. The resulting free thiol, generated after side-chain deprotection, can be used to form stable thioether conjugates with maleimide- or haloacetamide-type electrophiles, or to enable disulfide exchange strategies where appropriate. Such conjugation-ready cysteine motifs are useful for preparing defined biomolecule conjugates, affinity reagents, and analytical probes that rely on sulfur chemistry for attachment.

4. Protein Engineering

Fmoc-Cys(t-butylcarboxymethyl)-OH can be used in protein engineering contexts where cysteine-containing peptide segments or constrained linkers are needed to model or introduce reactive sulfur sites. The amino acid derivative's Fmoc chemistry supports incorporation into peptide constructs that later undergo thiol unmasking to generate a functional cysteine for crosslinking or site-specific attachment. The stereochemically defined cysteine center helps preserve side-chain orientation relevant to structure-function studies and to the design of thiol-mediated conjugation points. The protected thiol strategy also supports manufacturing of uniform peptide reagents used in protein modification and controlled assembly of cysteine-dependent architectures.

5. Pharmaceutical Intermediate Preparation

Fmoc-Cys(t-butylcarboxymethyl)-OH functions as a peptide synthesis-compatible intermediate for manufacturing routes that require protected cysteine building blocks for drug-like peptidomimetics and linker components. The Fmoc carbamate and tBu-Cm thiol protection provide orthogonality, allowing sequential deprotection and coupling steps that can be integrated into scalable fine chemical synthesis planning. The presence of both an Fmoc-protected amine and a free carboxylic acid supports conversion into defined amide-linked intermediates and facilitates downstream coupling to carboxylic acid or activated ester partners. Thiol unmasking after fragment assembly enables generation of cysteine-derived motifs used in final-stage derivatization, including attachment of solubilizing groups, conjugation handles, or sulfur-containing pharmacophore elements.

1. Novel Peptide-Based PD1 Immunomodulators Demonstrate Efficacy in Infectious Disease Vaccines and Therapeutics

2. Identification, Localization in the Central Nervous System and Novel Myostimulatory Effect of Allatostatins in Tenebrio molitor Beetle

3. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy

4. The effect of B-type allatostatin neuropeptides on crosstalk between the insect immune response and cold tolerance

5. Odorant binding protein based biomimetic sensors for detection of alcohols associated with Salmonella contamination in packaged beef